A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey
1997

Hormones and Breast Cancer Risk in Women

Sample size: 244 publication 10 minutes Evidence: moderate

Author Information

Author(s): HV Thomas, TJ Key, DS Allen, JW Moore, M Dowsett, IS Fentiman, DY Wang

Primary Institution: Imperial Cancer Research Fund

Hypothesis

Serum concentrations of oestradiol, testosterone, and luteal-phase progesterone are positively associated with risk of breast cancer, whereas serum sex hormone-binding globulin (SHBG) is negatively associated with risk.

Conclusion

The study suggests that while mean oestradiol concentration may be higher in women who develop breast cancer, the difference was not statistically significant.

Supporting Evidence

  • The mean oestradiol concentration was 12% higher in cases than controls.
  • Mid-cycle oestradiol concentration was 75% higher in cases compared to controls.
  • None of the hormone concentration differences were statistically significant.

Takeaway

The study looked at hormone levels in women to see if they affect breast cancer risk, but found that the differences weren't strong enough to be sure.

Methodology

The study involved 62 breast cancer cases and 182 matched control subjects, measuring hormone levels through blood samples collected over several years.

Potential Biases

Potential biases include matching criteria and the influence of metabolic effects of early cancer on hormone levels.

Limitations

The study's findings may not be conclusive due to the small sample size and the non-significant differences in hormone levels.

Participant Demographics

Women aged 34 years and above from the island of Guernsey.

Statistical Information

P-Value

0.04 for mid-cycle oestradiol concentration

Confidence Interval

(0.87-2.63) for oestradiol odds ratio

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication